Clinical trials
Breast - Female clinical trials
Below are recruiting breast - female clinical trials, each written for real people, not researchers. We’re tracking 3,705 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05954507Recruiting
PET/MRI scan to assess heart risk in sarcoidosis
This study checks whether a special heart scan called PET/MRI can predict how sarcoidosis may affect your heart. It may help doctors better estimate heart risk and plan follow-up based on scan findings.
CréteilAges 18 years+ - NCT04910503RecruitingPhase 4
Compare fluocinolone and dexamethasone implants for resistant eye swelling
This trial looks at which long-acting steroid implant works better for diabetic macular swelling that did not improve enough with past treatments. It may help patients by testing a treatment option aimed at improving vision when other eye injections have not worked well.
DijonAges 18 years+ - NCT06990737RecruitingPhase 2
Sentinel node biopsy for high-risk skin cancer of the head and neck
This trial is testing whether a procedure called sentinel lymph node biopsy (SLNB) can help manage high-risk skin cancer on the head and neck that has not spread to lymph nodes. It is for people whose skin cancer is considered high-risk due to features like size, depth, or location, and who are able to have surgery.
Sacramento, CaliforniaAges 18 years+ - NCT07359443RecruitingPhase 1
Chemo plus MRI-guided radiation before esophageal cancer surgery
This trial tests combining chemotherapy (FLOT) with a special type of MRI-guided radiation before surgery for esophageal adenocarcinoma. It aims to improve treatment results for patients with a specific type and stage of the disease.
Utrecht, UtrechtAges 18 years+ - NCT07359404Enrolling by invitationPhase 2
Sacituzumab Govitecan plus Bevacizumab for metastatic TNBC
This trial tests a combination of two drugs, Sacituzumab Govitecan and Bevacizumab, for people with advanced triple-negative breast cancer that has already been treated. The goal is to see if the combination works better than standard treatments.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06949007Recruiting
Yoga for persistent pain after torso surgery
This study tests whether yoga or a health education program can help reduce long-term pain that started after a torso surgery like a chest, breast, or abdominal operation. You must have had surgery at least 3 months ago with moderate pain, and be able to attend classes in person or virtually.
Boston, MassachusettsAges 18 years+ - NCT07356453RecruitingPhase 1
Study of PARG inhibitor FORX-428 for advanced solid tumors
This trial tests a new drug called FORX-428, which targets a protein called PARG, in people with advanced solid tumors. It is for patients whose cancer has not responded to prior treatments and who have specific genetic changes, such as BRCA mutations.
Palo Alto, CaliforniaAges 18 years+ - NCT07346716Recruiting
Medicines in breast milk and infant exposure
This trial studies how medicines you take while breastfeeding get into your breast milk and what that might mean for your baby. It could help you understand if your medication is safe while nursing.
CopenhagenAges 18 years+ - NCT06918808RecruitingPhase 2
Stem cell therapy for Crohn's fistula healing
This trial tests if a special stem cell treatment (called DB-3Q bmMSC-EVs) can help heal fistulas caused by Crohn's disease. It's for people who have already tried other treatments and still have actively draining fistulas.
Aurora, ColoradoAges 18–75 - NCT07340723RecruitingPhase 2
New treatment study for grade II acute GVHD after transplant
This study tests a new first-line therapy for patients who develop grade II acute graft-versus-host disease (GVHD) after their first stem cell transplant. It aims to find better ways to treat this complication.
Beijing, Beijing MunicipalityAges 14 years+ - NCT07331532Recruiting
New pet scan to detect annexin a2 in lung tumors
This trial tests a new injection called 68Ga-PFA2 for PET/CT scans to find a protein called Annexin A2 in lung cancer tumors. It aims to see if this scan can better detect or characterize these tumors in patients who will have a biopsy or surgery soon.
Beijing, Beijing MunicipalityAges 18–80 - NCT06054880RecruitingPhase 4
Blue dye to check ureter openness during surgery
This trial tests a blue dye (Indigotindisulfonate Sodium) given during surgery to help doctors see if the tube from your kidney to bladder (ureter) is open. It's for people who are already having a surgery where that check is needed.
Albany, New YorkAges 18–85 - NCT07319130Enrolling by invitation
Testing a new PET scan for Nectin-4-positive tumors
This trial tests a new imaging injection (a radioactive tracer called 68Ga) that sticks to a protein called Nectin-4, which is often found on cancer cells. The goal is to see if this scan can better find tumors in people with certain solid cancers, such as bladder, breast, or lung cancer.
Suzhou, JiangsuAges 18 years+ - NCT07295171Recruiting
PET scan study with oral radioactive sugar
This study tests if giving a radioactive sugar drink (instead of an IV) before a PET scan works well for cancer imaging. If you already had a standard PET scan, you may be eligible for a second scan using the oral version.
Vancouver, British ColumbiaAges 19 years+ - NCT07312903RecruitingPhase 1
Study of DPTX3186 for advanced solid tumors with Wnt pathway activation
This trial tests an experimental oral drug (DPTX3186) for people with advanced solid tumors that are linked to the Wnt pathway. It may be an option if standard treatments are no longer available.
San Antonio, TexasAges 18 years+ - NCT07312786Recruiting
Virtual app for breast and colorectal cancer survivors
This study tests if a virtual app can help people who have finished treatment for breast or colorectal cancer feel supported and stay healthy. It looks at whether using the app is easy and helpful for cancer survivors.
Saint John, New BrunswickAges 18 years+ - NCT06673160Recruiting
Increasing breast milk production for mothers of premature babies
This study tests whether a special pumping schedule helps mothers of very premature babies (born before 32 weeks) produce more breast milk. It is designed for babies born weighing less than 1500 grams and who are cared for at our hospital.
Birmingham, AlabamaAges Up to 4 weeks - NCT06797037Recruiting
Nurse-led support for cancer patients on oral treatment
This trial tests a program where an advanced practice nurse coordinates your care while you take oral cancer medication at home. You might benefit if you want extra check-ins by phone and are comfortable with two nurse visits at home over six months.
ToulouseAges 18 years+ - NCT02886104Recruiting
Surgery versus local ablation for certain liver metastases
This trial compares two ways to treat colorectal cancer that has spread to the liver: removing liver tumors with surgery versus destroying them in place with local ablation. It may help doctors learn which approach works best for people whose disease can be fully treated and who have enough healthy liver left.
Guangzhou, GuangdongAges 18–80 - NCT07163325RecruitingPhase 1
Testing a new drug for advanced solid tumors
This trial tests a new oral drug called EP102 for people with certain advanced cancers that have stopped responding to standard treatments. It aims to see if the drug is safe and works by targeting a protein called METTL3.
BrusselsAges 18 years+ - NCT06934278RecruitingPhase 3
Plasma vs salt water for scoliosis surgery in kids
This study compares two types of fluids—one made from donated human blood plasma and one a standard salt-solution—given during scoliosis surgery in children and teenagers. The goal is to see which fluid helps patients recover safely and with fewer complications.
HelsinkiAges 10–21 - NCT06803914Recruiting
Returning to sports after hip replacement
This study looks at how people move and return to sports after total hip replacement surgery. If you are an active person planning to have a hip replacement, this trial may help understand your recovery.
MérignacAges 18–65 - NCT07001332Recruiting
High-risk heart stent procedure study
This study tests a new device to help people with high-risk blockages in their heart arteries during a stent procedure. It compares the new device to standard treatment to see if it is safe and effective.
Phoenix, ArizonaAges 18–88 - NCT06502353Recruiting
Plexaa before gender-affirming mastectomy
This trial tests a product called Plexaa, which is applied before surgery to help prepare the skin and improve healing. It is for transgender or non-binary people having a specific type of mastectomy (breast removal) for gender affirmation.
Palo Alto, CaliforniaAges 18 years+
Hear when a new Breast - Female trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for breast - female?
- Yes. Clin2 currently lists 3,705 recruiting breast - female studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a breast - female trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a breast - female trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.